Peyman Hadji

5.4k total citations · 1 hit paper
120 papers, 3.0k citations indexed

About

Peyman Hadji is a scholar working on Orthopedics and Sports Medicine, Oncology and Genetics. According to data from OpenAlex, Peyman Hadji has authored 120 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Orthopedics and Sports Medicine, 53 papers in Oncology and 24 papers in Genetics. Recurrent topics in Peyman Hadji's work include Bone health and osteoporosis research (78 papers), Bone health and treatments (47 papers) and Bone Metabolism and Diseases (22 papers). Peyman Hadji is often cited by papers focused on Bone health and osteoporosis research (78 papers), Bone health and treatments (47 papers) and Bone Metabolism and Diseases (22 papers). Peyman Hadji collaborates with scholars based in Germany, United Kingdom and United States. Peyman Hadji's co-authors include Ioannis Kyvernitakis, Karel Kostev, L Hellmeyer, Eugène McCloskey, O. Hars, Volker Ziller, Barbara Obermayer‐Pietsch, Steven Boonen, Thomas Nickélsen and Clare Barker and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Peyman Hadji

107 papers receiving 2.9k citations

Hit Papers

Goal-directed osteoporosis treatment: ASBMR/BHOF task for... 2024 2026 2025 2024 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024
    2024 33 citations Felicia Cosman, E. Michael Lewiecki et al. Journal of Bone and Mineral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peyman Hadji Germany 32 2.0k 1.4k 748 619 321 120 3.0k
George Wells Canada 25 1.9k 1.0× 1.1k 0.8× 717 1.0× 776 1.3× 551 1.7× 37 3.5k
Astrid Fahrleitner‐Pammer Austria 35 2.8k 1.4× 2.1k 1.5× 1.6k 2.2× 853 1.4× 320 1.0× 105 4.3k
H.A.P. Pols Netherlands 20 2.0k 1.0× 810 0.6× 799 1.1× 889 1.4× 426 1.3× 39 3.4k
Marjorie M. Luckey United States 25 2.6k 1.3× 1.2k 0.9× 846 1.1× 1.1k 1.7× 619 1.9× 31 3.5k
Sophie A. Jamal Canada 37 2.9k 1.5× 1.6k 1.2× 905 1.2× 1.0k 1.7× 705 2.2× 76 5.5k
Angelo A. Licata United States 26 2.1k 1.0× 1.6k 1.1× 918 1.2× 701 1.1× 392 1.2× 72 3.4k
C. H. Chesnut United States 21 1.9k 0.9× 991 0.7× 681 0.9× 514 0.8× 373 1.2× 40 2.6k
L. Sinigaglia Italy 33 1.5k 0.7× 778 0.6× 566 0.8× 499 0.8× 669 2.1× 99 3.6k
Francisco Bandeira Brazil 28 1.0k 0.5× 987 0.7× 458 0.6× 627 1.0× 946 2.9× 125 3.1k
Anne E. de Papp United States 22 1.9k 0.9× 1.2k 0.8× 770 1.0× 353 0.6× 1.0k 3.1× 36 2.9k

Countries citing papers authored by Peyman Hadji

Since Specialization
Citations

This map shows the geographic impact of Peyman Hadji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peyman Hadji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peyman Hadji more than expected).

Fields of papers citing papers by Peyman Hadji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peyman Hadji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peyman Hadji. The network helps show where Peyman Hadji may publish in the future.

Co-authorship network of co-authors of Peyman Hadji

This figure shows the co-authorship network connecting the top 25 collaborators of Peyman Hadji. A scholar is included among the top collaborators of Peyman Hadji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peyman Hadji. Peyman Hadji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biver, Emmanuel, Peyman Hadji, Edith Bonnelye, et al.. (2025). Bone Effects of Anti-Cancer Treatments in 2024. Calcified Tissue International. 116(1). 54–54.
2.
Cosman, Felicia, E. Michael Lewiecki, Richard Eastell, et al.. (2024). Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024. Journal of Bone and Mineral Research. 39(10). 1393–1405. 33 indexed citations breakdown →
3.
Hadji, Peyman, et al.. (2024). Bone evaluation study-2: update on the epidemiology of osteoporosis in Germany. Archives of Osteoporosis. 19(1). 26–26. 6 indexed citations
4.
5.
Hadji, Peyman, et al.. (2021). Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data. Archives of Gynecology and Obstetrics. 304(3). 703–712. 15 indexed citations
6.
Kurth, Andreas, et al.. (2020). Informationen der Gesellschaft. Osteologie/Osteology. 29(1). 84–85. 1 indexed citations
7.
O’Kelly, James, et al.. (2020). PMS3 Real-World Effectiveness of Osteoporosis Treatments in Germany. Value in Health. 23. S592–S592. 1 indexed citations
8.
Kyvernitakis, Ioannis, et al.. (2020). Effect of progestogen-only contraception on premenopausal fracture risk: a case-control study. Osteoporosis International. 31(9). 1801–1806. 3 indexed citations
9.
Fahrleitner‐Pammer, Astrid, Νικόλαος Παπαϊωάννου, Evelien Gielen, et al.. (2017). Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium. Archives of Osteoporosis. 12(1). 58–58. 46 indexed citations
10.
Kyvernitakis, Ioannis, et al.. (2017). Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporosis International. 29(1). 135–142. 63 indexed citations
11.
Rabe, T., Nico Bruyniks, Edgar C. Merkle, et al.. (2016). Selective Estrogen Receptor Modulators – an Update (Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine [DGGEF] and the German Professional Association of Gynecologists [BVF]). 12(4). 287–317. 1 indexed citations
12.
Rabe, T., Michael Ludwig, E. Merkle, et al.. (2013). Depotgestagene zur Kontrazeption bei der FrauGemeinsame Stellungnahme der Deutschen Gesellschaft für Gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF) e.V. und des Berufsverbands der Frauenärzte (BVF) e. V.. 10(1). 18–42.
13.
Cauley, Jane A., Dennis M. Black, Steven Boonen, et al.. (2010). Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial. Journal of Bone and Mineral Research. 26(5). 984–992. 26 indexed citations
14.
Ziller, Volker, et al.. (2010). Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene. Climacteric. 14(2). 228–235. 16 indexed citations
15.
Rabe, T., et al.. (2009). Einfluss von hormonellen Kontrazeptiva auf das Größenwachstum und den Knochenbau von 12-14-jährigen Mädchen: Stellungnahme der DGGEF. Journal für Kardiologie (Krause & Pachernegg GmbH). 6(5). 204–213. 1 indexed citations
16.
Obermayer‐Pietsch, Barbara, Fernando Marín, Eugène McCloskey, et al.. (2008). Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment. Journal of Bone and Mineral Research. 23(10). 1591–1600. 204 indexed citations
17.
Rabe, T., et al.. (2004). Hormonersatztherapie - Nutzen und Risiken. Journal für Kardiologie (Krause & Pachernegg GmbH). 1(2). 155–165. 3 indexed citations
18.
Gottschalk, M., et al.. (2004). Möglichkeiten und Grenzen des Einsatzes von Raloxifen in Prävention und Therapie der postmenopausalen Osteoporose. 11(1). 30–35.
19.
Hadji, Peyman, et al.. (2001). Einfluß der Hormone Replacement Therapy (HRT) auf die bildgebende Diagnostik. Journal für Kardiologie (Krause & Pachernegg GmbH). 8(2). 22–26. 1 indexed citations
20.
Hadji, Peyman, et al.. (2000). The effect of long-term, non-suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women. European Journal of Endocrinology. 142(5). 445–450. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Wells Breakdown of academic impact, for papers by Astrid Fahrleitner‐Pammer Breakdown of academic impact, for papers by H.A.P. Pols Breakdown of academic impact, for papers by Marjorie M. Luckey Breakdown of academic impact, for papers by Sophie A. Jamal Breakdown of academic impact, for papers by Angelo A. Licata Breakdown of academic impact, for papers by C. H. Chesnut Breakdown of academic impact, for papers by L. Sinigaglia Breakdown of academic impact, for papers by Francisco Bandeira Breakdown of academic impact, for papers by Anne E. de Papp
Rankless by CCL
2026